ARTELO BIOSCIENCES, INC. Total Assets

• ARTELO BIOSCIENCES, INC. showed a decrease of -40.4% in Total Assets from 2024 to 2025.
• This data is from ARTELO BIOSCIENCES, INC.'s annual report (Form 10-K), filed with the SEC on February 24, 2026.
• XBRL data for this metric is available from 2014 to 2025 (13 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q1 2015: $8.1 thousand | Q2 2015: $12.6 thousand | Q4 2015: $4.0 thousand | Q1 2016: $3.6 thousand | Q2 2016: $3.6 thousand | Q4 2016: $3.6 thousand | Q1 2017: $13.5 thousand | Q2 2017: $227.8 thousand | Q4 2017: $430.3 thousand | Q1 2018: $541.1 thousand | Q2 2018: $401.0 thousand | Q4 2018: $165.4 thousand | Q1 2019: $484.3 thousand | Q2 2019: $1.15 million | Q4 2019: $5.55 million | Q1 2020: $4.15 million | Q2 2020: $3.49 million | Q4 2020: $9.54 million | Q1 2021: $13.44 million | Q2 2021: $12.34 million | Q4 2021: $29.00 million | Q1 2022: $26.70 million | Q2 2022: $24.41 million | Q3 2022: $22.42 million | Q1 2023: $18.48 million | Q2 2023: $16.88 million | Q3 2023: $15.50 million | Q1 2024: $10.35 million | Q2 2024: $8.33 million | Q3 2024: $7.14 million | Q1 2025: $3.52 million | Q2 2025: $4.36 million | Q3 2025: $4.27 million.
• Over the full 13 years of available data (2014 to 2025), ARTELO BIOSCIENCES, INC.'s Total Assets has grown by 18,914.3%.
• Historical annual values: Fiscal year 2025: $2.80 million | Fiscal year 2024: $4.70 million | Fiscal year 2023: $13.04 million | Fiscal year 2022: $20.42 million | Fiscal year 2021: $28.25 million | Fiscal year 2021: $12.64 million | Fiscal year 2020: $4.38 million | Fiscal year 2019: $6.48 million | Fiscal year 2018: $397.0 thousand | Fiscal year 2017: $574.3 thousand | Fiscal year 2016: $3.6 thousand | Fiscal year 2015: $17.0 thousand | Fiscal year 2014: $14.7 thousand.
• Data sourced from SEC EDGAR public filings as of August 5, 2026.

Last verified: August 5, 2026